Skip to main content

and
  1. Article

    Open Access

    Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity

    Palmitoylethanolamide (PEA) is a pleiotropic endogenous lipid mediator currently used as a “dietary food for special medical purposes” against neuropathic pain and neuro-inflammatory conditions. Several mechan...

    Stefania Petrosino, Aniello Schiano Moriello, Roberta Verde in Journal of Neuroinflammation (2019)

  2. Article

    Open Access

    Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis

    Despite the precise pathogenesis of atopic dermatitis (AD) is unknown, an immune dysregulation that causes Th2-predominant inflammation and an intrinsic defect in skin barrier function are currently the two ma...

    Francesca Abramo, Luca Campora, Francesco Albanese in BMC Veterinary Research (2014)

  3. Article

    Rimonabant Precipitates Anxiety in Rats Withdrawn from Palatable Food: Role of the Central Amygdala

    The anti-obesity medication rimonabant, an antagonist of cannabinoid type-1 (CB1) receptor, was withdrawn from the market because of adverse psychiatric side effects, including a negative affective state. We inve...

    Angelo Blasio, Attilio Iemolo, Valentina Sabino in Neuropsychopharmacology (2013)

  4. No Access

    Article

    Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1

    The authors uncover a mechanism for the known antitumor effect exerted by neural precursor cells (NPCs). NPCs migrate into tumors in vivo and secrete endovanilloids, which act as agonists for TRPV1, their recepto...

    Kristin Stock, Jitender Kumar, Michael Synowitz, Stefania Petrosino in Nature Medicine (2012)

  5. Article

    Open Access

    Effect of the Cannabinoid Receptor-1 antagonist SR141716A on human adipocyte inflammatory profile and differentiation

    Obesity is characterized by inflammation, caused by increase in proinflammatory cytokines, a key factor for the development of insulin resistance. SR141716A, a cannabinoid receptor 1 (CB1) antagonist, shows si...

    Ravi Murumalla, Karima Bencharif, Lydie Gence in Journal of Inflammation (2011)

  6. No Access

    Article

    Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB1 receptors: a keratinocyte-dependent effect

    Ultraviolet radiation is the major environmental insult to the skin and stimulates the synthesis of melanin in melanocytes, which then distribute it to the neighboring keratinocytes where it confers photo-prot...

    Sofia Magina, Carina Esteves-Pinto, Eduardo Moura in Archives of Dermatological Research (2011)

  7. Article

    Open Access

    Possible Anandamide and Palmitoylethanolamide involvement in human stroke

    Endocannabinoids (eCBs) are ubiquitous lipid mediators that act on specific (CB1, CB2) and non-specific (TRPV1, PPAR) receptors. Despite many experimental animal studies proved eCB involvement in the pathogene...

    Marcello Naccarato, Daniela Pizzuti, Stefania Petrosino in Lipids in Health and Disease (2010)

  8. Article

    Open Access

    Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients

    The endocannabinoids, anandamide and 2-AG, are produced by adipocytes, where they stimulate lipogenesis via cannabinoid CB1 receptors and are under the negative control of leptin and insulin. Endocannabinoid leve...

    Giovanni Annuzzi, Fabiana Piscitelli, Lucrezia Di Marino in Lipids in Health and Disease (2010)

  9. No Access

    Article

    Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis

    Inflammatory bowel disease affects millions of individuals; nevertheless, pharmacological treatment is disappointingly unsatisfactory. Cannabidiol, a safe and non-psychotropic ingredient of marijuana, exerts p...

    Francesca Borrelli, Gabriella Aviello, Barbara Romano in Journal of Molecular Medicine (2009)

  10. Article

    Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels

    The endocannabinoid-inactivating enzyme, fatty acid amide hydrolase (FAAH), and the transient receptor potential vanilloid type-1 (TRPV1) channel are new targets for the development of anxiolytic drugs. We stu...

    Vincenzo Micale, Luigia Cristino, Alessandra Tamburella in Neuropsychopharmacology (2009)

  11. No Access

    Article

    Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice

    Gastric emptying regulates food intake. Oleoylethanolamide (OEA), an endogenous acylethanolamide chemically related to the endocannabinoid anandamide, inhibits food intake, but its effect on gastric emptying i...

    Gabriella Aviello, Isabel Matias, Raffaele Capasso in Journal of Molecular Medicine (2008)

  12. Article

    Open Access

    Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon

    Colorectal cancer is an increasingly important cause of death in Western countries. Endocannabinoids inhibit colorectal carcinoma cell proliferation in vitro. In this paper, we investigated the involvement of ...

    Angelo A. Izzo, Gabriella Aviello, Stefania Petrosino in Journal of Molecular Medicine (2008)

  13. Article

    Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro

    In this study, we investigated the mechanism of S100B neurotoxicity and the effect of cannabinoids, in C6 cells treated with 1-methyl-4-phenyl 1,2,3,6 tetrahydropyridine (MPTP) and co-cultured with differentia...

    Teresa Iuvone, Giuseppe Esposito, Daniele De Filippis in Journal of Molecular Medicine (2007)

  14. No Access

    Article

    Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats

    The endocannabinoid system is upregulated in both human inflammatory bowel diseases and experimental models of colitis. In this study, we investigated whether this upregulation is a marker also of celiac disea...

    Giuseppe D’Argenio, Stefania Petrosino, Carmen Gianfrani in Journal of Molecular Medicine (2007)